Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus

Declining trend in valproate use in Finland among females of childbearing age in 2012-2016 - a nationwide registry-based outpatient study

(2018) L. J. Virta et al.   EUROPEAN JOURNAL OF NEUROLOGY

Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences

(2018) Felix Zahnert et al.   Frontiers in Neurology

Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus

(2017) Jerome Niquet et al.   EPILEPSIA

Long-term outcome in adolescent-onset generalized genetic epilepsies

(2017) Bernd J. Vorderwülbecke et al.   EPILEPSIA

Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology

(2017) Robert S. Fisher et al.   EPILEPSIA

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

(2017) Ingrid E. Scheffer et al.   EPILEPSIA

Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany

(2017) Isabel Steinig et al.   EPILEPSIA

Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals

(2017) Adam Strzelczyk et al.   EPILEPSY & BEHAVIOR

Anticonvulsant drugs for generalized tonic-clonic epilepsy

(2017) Giangennaro Coppola et al.   EXPERT OPINION ON PHARMACOTHERAPY

Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy—A monocenter survey

(2017) Bernhard J. Steinhoff et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence

(2017) Laurent M. Willems et al.   Expert Review of Clinical Pharmacology

The Burden of Severely Drug-Refractory Epilepsy: A Comparative Longitudinal Evaluation of Mortality, Morbidity, Resource Use, and Cost Using German Health Insurance Data

(2017) Adam Strzelczyk et al.   Frontiers in Neurology

Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy

(2016) Jacint Sala-Padró et al.   CLINICAL NEUROPHARMACOLOGY

Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein

(2016) Martyn D. Wood et al.   EPILEPSIA

Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies

(2016) Elinor Ben-Menachem et al.   NEUROLOGY

Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus

(2016) Adam Strzelczyk et al.   Expert Review of Clinical Pharmacology

Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies

(2015) Reetta Kälviäinen et al.   EPILEPSIA

Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats

(2015) Nina Dupuis et al.   EPILEPSIA

Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures

(2015) Lara Kay et al.   EPILEPSIA

A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures

(2015) Pavel Klein et al.   EPILEPSIA

Brivaracetam augments short-term depression and slows vesicle recycling

(2015) Xiaofeng Yang et al.   EPILEPSIA

A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus

(2015) Eugen Trinka et al.   EPILEPSIA

Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action

(2015) Jean-Marie Nicolas et al.   EPILEPSIA

An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam

(2015) Stephen L. Yates et al.   EPILEPSY & BEHAVIOR

Brivaracetam Differentially Affects Voltage-Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons

(2014) Isabelle Niespodziany et al.   CNS Neuroscience & Therapeutics

A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria

(2014) Bernhard J. Steinhoff et al.   EPILEPSY RESEARCH

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial

(2013) Victor Biton et al.   EPILEPSIA

Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial

(2013) Patrick Kwan et al.   EPILEPSIA

Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial

(2013) Philippe Ryvlin et al.   EPILEPSIA

Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: A single centre evaluation

(2013) Jan Novy et al.   EPILEPSY RESEARCH

Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up

(2012) Julia Geithner et al.   EPILEPSIA

Clinical experience with oral lacosamide as adjunctive therapy in adult patients with uncontrolled epilepsy: A multicentre study in epilepsy clinics in the United Kingdom (UK)

(2012) Lorena Flores et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Relationship of clinical and quality of life trajectories following the onset of seizures: Findings from the UK MESS Study

(2011) Ann Jacoby et al.   EPILEPSIA

Remission and relapse in a drug-resistant epilepsy population followed prospectively

(2011) Brian Callaghan et al.   EPILEPSIA

The long-term retention of zonisamide in a large cohort of people with epilepsy at a tertiary referral centre

(2011) Claudia B. Catarino et al.   EPILEPSY RESEARCH

Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials

(2011) Philippe Ryvlin et al.   LANCET NEUROLOGY

Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents

(2010) Maria Mazurkiewicz-Bełdzińska et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

(2009) Patrick Kwan et al.   EPILEPSIA

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A

(2008) A Matagne et al.   BRITISH JOURNAL OF PHARMACOLOGY

Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures

(2008) S. Noachtar et al.   NEUROLOGY

Cost of Epilepsy

(2008) Adam Strzelczyk et al.   PHARMACOECONOMICS